70 results
6-K
EX-99.1
PRFX
PainReform Ltd
26 Jun 24
PainReform Completes Enrollment in the Second Part
4:15pm
limited experience managing clinical trials; our ability to retain key personnel and recruit additional employees; our reliance on third parties
6-K
EX-99.1
PRFX
PainReform Ltd
31 May 24
PainReform Announces Receipt of Nasdaq Minimum Bid Price Notification
4:24pm
trials; our ability to retain key personnel and recruit additional employees; our reliance on third parties for the conduct of clinical trials, product
6-K
EX-99.2
PRFX
PainReform Ltd
15 May 24
Condensed Financial Statements
4:15pm
PRF-110 and future product candidates;
our limited experience managing clinical trials;
our ability to retain key personnel and recruit additional
6-K
EX-99.3
PRFX
PainReform Ltd
15 May 24
Condensed Financial Statements
4:15pm
clinical trials; our ability to retain key personnel and recruit additional employees; our reliance on third parties for the conduct of clinical trials
424B4
PRFX
PainReform Ltd
17 Apr 24
Prospectus supplement with pricing info
4:14pm
and recruit additional employees;
our reliance on third parties for the conduct of clinical trials, product manufacturing and development;
the impact
6-K
EX-99.1
uqw5j sdg0f1oe
16 Apr 24
PainReform Announces Pricing of $4 Million Public Offering
8:17am
F-1/A
0pff32u2hkc5p tu4r95
15 Apr 24
Registration statement (foreign) (amended)
9:41am
6-K
EX-99.1
zzn1nozteft9
9 Apr 24
Current report (foreign)
9:07am
6-K
EX-99.1
256rl0x6f dr
2 Apr 24
PainReform Reaches 50% Enrollment in the Second Part of its Phase 3 Clinical
8:35am
POS AM
j6o2qxqq84k2w9swy fv
13 Mar 24
Prospectus update (post-effective amendment)
8:00am
F-1
l9u8xjn
1 Mar 24
Registration statement (foreign)
4:34pm
6-K
EX-99.1
y6l65exg 3hfz20n
1 Mar 24
PainReform Provides Year-End Business Update
8:09am
424B3
g112 1x7tp6
19 Jan 24
Prospectus supplement
4:30pm
F-3
4b4ftk
12 Jan 24
Shelf registration (foreign)
4:15pm
6-K
EX-99.1
90idg9
3 Jan 24
PainReform Reports Successful Head-to-Head Comparison
8:36am
6-K
EX-99.1
myx8r628nuvsrxn1o
26 Dec 23
PainReform Announces Exercise of Warrants for Approximately $1.3 Million in Gross
6:08pm
6-K
EX-99.3
7q03qh
15 Nov 23
Condensed Financial Statements
4:09pm
6-K
EX-99.2
bobv 9tk2ck7f
15 Nov 23
Condensed Financial Statements
4:09pm
6-K
EX-99.1
ml9nnakenmbd5fxwpe
11 Sep 23
Trial completion and results expected in mid-2024
8:41am